Marks Group Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Marks Group Wealth Management's AMGN Position: Q2 2026 in Review
Marks Group Wealth Management increased its Amgen (AMGN) stake by 1.3% in Q2 2026, buying an estimated $28.4K and bringing the position to 6,591 shares worth $2.39M. The position accounts for 0.21% of the portfolio, ranked #116.
Marks Group Wealth Management first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.49M in Q3 2023. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Marks Group Wealth Management held 6,591 shares of Amgen worth $2.39M as of Q2 2026.
- Marks Group Wealth Management bought 83 Amgen shares in Q2 2026, an estimated $28.4K.
- Amgen made up 0.21% of Marks Group Wealth Management's portfolio in Q2 2026, its #116 holding.
- Marks Group Wealth Management first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Marks Group Wealth Management's Amgen position peaked at $2.49M in Q3 2023.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Marks Group Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.